Next-Generation Sequencing for DLBCL Classification
Reinholz M., et al. Next-Generation Sequencing for DLBCL Classification. J Clin Oncol. 2016;34(Suppl):abstr 11559.
Categories
Filter by Topics
AACR2023 ALK aplastic anemia AA Autoimmune Disorder B-cell lymphoma Biology of neoplasia Biomarkers Bladder Cancer bone Brain Breast Cancer CD3 Cells Cerebrospinal Fluid clinical trial cold tumor Colorectal cancer Comparison study CXCL12 Cytokines Developmental Immunotherapy Developmental Therapeutics Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Drug sensitivity EHE cancer Encephalophy EPCORE NHL-1 ERBB3 FFPE Gene Expression Profiling Genetic Polymorphism Heart Histone Deacetylase Inhibitors hot tumor HTG EdgeSeq Custom Assays HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq Lung Fusion Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq System HTP Immune Checkpoint Inhibitors Immune Response Immune-related Colitis Immuno-Oncology IMMUNOSARC Immunotherapy IOA- 244 IRP Kidney Liposarcoma liver Liver Lung lungs lymphoma Lymphoma Melanoma melanoma Microenvironment miRNA miRNA WTA Molecular Characterization Nash and Fibrosis Natural Killer Cells Nestin+ Neurologic non-Hodgkin Lymphoma Non-Hodgkin lymphoma NHL OBP Oesophageal Adenocarcinoma Oral cancer oral squamous cell carcinoma OSCC PanB Pancreas pancreatic ductal adenocarcinoma PDAC Parkinson's Disease Pathway Analysis PDX model PI3K inhibitors PIP Plasma Platform Comparison Programmed cell death protein 1 Prostate qNPA qPCR Radioimmunotherapy Rheumatoid Arthritis Sarcoma Serum Signatures soft tissue sarcoma Sub-typing Survival plots T cells Thymic Carcinoma Tislelizumab TME Transplantation Treatment Outcome Treatment Targets Tumor Biology Tumor Immunobiology Tumor infiltrating lymphocytes Zanubrutinlb2016
2015
Targeted RNA Sequencing for simultaneous expression profiling and detection of gene rearrangements in FFPE biopsies.
Maddula K., et al. Targeted RNA Sequencing for simultaneous expression profiling and detection of gene rearrangements in FFPE biopsies. Poster session presented at: Advances in Genome Biology and Technology; 2015; Marco Island, FL.
- Topics:
- ALK
- Cells
- HTG EdgeSeq Lung Fusion Assay
Reproducibility and Bias of miRNA Profiling with the HTG EdgeSeq Targeted Capture and Sequencing Assay
Barczak A.J., et al. Reproducibility and Bias of miRNA Profiling with the HTG EdgeSeq Targeted Capture and Sequencing Assay. Poster session presented at: The External RNA Control Consortium (ERCC) 2015 meeting.
HTG EdgeSeq Oncology Biomarker Panel (OBP), an NGS-Based Expression Assay for Measuring 2,532 Oncology-Related Genes in FFPE Tissue in Different Sample Types
Reinholz M., et al. HTG EdgeSeq Oncology Biomarker Panel (OBP), an NGS-Based Expression Assay for Measuring 2,532 Oncology-Related Genes in FFPE Tissue in Different Sample Types. Poster session presented at: 8th GTCBio Oncology Biomarkers Conference; 2015, San Diego, CA.
2014
Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing
Thompson D., et al. Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing. Poster session presented at: 64th annual meeting of the American Society of Human Genetics; 2014 October 18-22; San Diego, CA
Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing
Thompson D., et al. Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing. Poster session presented at: Merck Technology Symposium; 2014 May; Long Branch, NJ.
- Categories
- Posters
FGFR and FGF ligand overexpression in lung cancer: Implications for targeted therapy.
Maddula K., et al. FGFR and FGF ligand overexpression in lung cancer: Implications for targeted therapy. J Clin Oncol. 2014;32(Suppl 5):abstr 11080.
Non-small cell lung cancer histological sub-typing by gene expression analysis from FFPE tissue.
Wang E., et al. Non-small cell lung cancer histological sub-typing by gene expression analysis from FFPE tissue. Cancer Res. 2014;74(19 Suppl):abstr 1877.
Download pdf 2.2MB
View External Link
RNA expression based screening of ALK Gene Fusion from NSCLC FFPE samples.
Maddula K., et al. RNA expression based screening of ALK Gene Fusion from NSCLC FFPE samples. Cancer Res. 2014;74(19 Suppl):abstr 1904.
2013
Development of an automated RNA-based nuclease protection assay for the detection of expressed EML-ALK fusions, EGFR and KRAS mutations in NSCLC.
Rounseville M., et al. Development of an automated RNA-based nuclease protection assay for the detection of expressed EML-ALK fusions, EGFR and KRAS mutations in NSCLC. J Clin Oncol. 2013;31(Suppl); abstr e22185.
- Topics:
- HTG EdgeSeq System
- qNPA
miRNA Biomarker Identification Using a Sequencing-Based Nuclease Protection Assay (NPSeq™).
Seligmann B., et al. miRNA Biomarker Identification Using a Sequencing-Based Nuclease Protection Assay (NPSeq™). J Biomol Tech. 2013 May;24(Suppl).
Comparison of qNPA vs qPCR on FFPE tissue
Rounseville M., et al. Comparison of qNPA vs qPCR on FFPE tissue. Cancer Res. 2013;73(8 Suppl):abstr 4133.
Page last updated May 22, 2023